Search by Drug Name or NDC
NDC 00407-2707-18 Optison 10; .22 mg/mL; mg/mL Details
Optison 10; .22 mg/mL; mg/mL
Optison is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GE Healthcare Inc.. The primary component is HUMAN ALBUMIN MICROSPHERES; PERFLUTREN.
Product Information
| NDC | 00407-2707 |
|---|---|
| Product ID | 0407-2707_63524386-08e9-49e4-aafd-91057f33ebf4 |
| Associated GPIs | 94500075401820 |
| GCN Sequence Number | 064507 |
| GCN Sequence Number Description | perflutren protein-A microsphr VIAL 0.22MG/ML INTRAVEN |
| HIC3 | A6V |
| HIC3 Description | CARDIOVASCULAR DIAGNOSTICS,NON-RADIOPAQUE AGENTS |
| GCN | 14454 |
| HICL Sequence Number | 021754 |
| HICL Sequence Number Description | PERFLUTREN PROTEIN-A MICROSPHR |
| Brand/Generic | Brand |
| Proprietary Name | Optison |
| Proprietary Name Suffix | Perflutren Protein-Type A Microspheres |
| Non-Proprietary Name | Human Albumin Microspheres and Perflutren |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10; .22 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | HUMAN ALBUMIN MICROSPHERES; PERFLUTREN |
| Labeler Name | GE Healthcare Inc. |
| Pharmaceutical Class | Contrast Agent for Ultrasound Imaging [EPC], Contrast Agent for Ultrasound Imaging [EPC], Ultrasound Contrast Activity [MoA], Ultrasound Contrast Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020899 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00407-2707-18 (00407270718)
| NDC Package Code | 0407-2707-18 |
|---|---|
| Billing NDC | 00407270718 |
| Package | 18 VIAL, SINGLE-USE in 1 CARTON (0407-2707-18) / 3 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 2002-01-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |